Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.08 HKD
−87.00 M HKD
583.17 M HKD
148.81 M
About ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY
Sector
Industry
CEO
Zhong Zhao
Website
Headquarters
Hangzhou
Founded
2012
ISIN
CNE100004JD2
FIGI
BBG011F7CXT7
Zylox-Tonbridge Medical Technology Co., Ltd. engages in the production and sales of neurovascular and peripheral-vascular interventional surgical devices. The company was founded by Zhong Zhao on November 6, 2012 and is headquartered in Hangzhou, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2190 is 11.30 HKD — it has increased by 1.62% in the past 24 hours. Watch ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY stocks are traded under the ticker 2190.
2190 stock has risen by 1.99% compared to the previous week, the month change is a 0.71% rise, over the last year ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY has showed a −5.99% decrease.
2190 reached its all-time high on Jul 5, 2021 with the price of 60.80 HKD, and its all-time low was 7.20 HKD and was reached on Sep 22, 2023. View more price dynamics on 2190 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2190 stock is 1.62% volatile and has beta coefficient of 0.67. Track ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY stock price on the chart and check out the list of the most volatile stocks — is ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY there?
Today ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY has the market capitalization of 3.64 B, it has decreased by −0.36% over the last week.
Yes, you can track ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financials in yearly and quarterly reports right on TradingView.
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY is going to release the next earnings report on Mar 18, 2025. Keep track of upcoming events with our Earnings Calendar.
2190 net income for the last half-year is 74.62 M HKD, while the previous report showed −46.69 M HKD of net income which accounts for 259.82% change. Track more ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financial stats to get the full picture.
No, 2190 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 765.00 employees. See our rating of the largest employees — is ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY EBITDA is 4.70 M HKD, and current EBITDA margin is −22.50%. See more stats in ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financial statements.
Like other stocks, 2190 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY stock shows the buy signal. See more of ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.